Logo image of XYLO

XYLO TECHNOLOGIES LTD (XYLO) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:XYLO - US58471G5080 - ADR

5.07 USD
0 (0%)
Last: 8/21/2025, 8:00:02 PM
5.29 USD
+0.22 (+4.34%)
After Hours: 8/14/2025, 8:00:02 PM

XYLO Key Statistics, Chart & Performance

Key Statistics
Market Cap9.61M
Revenue(TTM)29.86M
Net Income(TTM)-6.03M
Shares1.89M
Float1.73M
52 Week High5.85
52 Week Low2.71
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-3.46
PEN/A
Fwd PE0.79
Earnings (Next)N/A N/A
IPO2006-02-27
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


XYLO short term performance overview.The bars show the price performance of XYLO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

XYLO long term performance overview.The bars show the price performance of XYLO in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of XYLO is 5.07 USD. In the past month the price decreased by -0.98%. In the past year, price increased by 40.44%.

XYLO TECHNOLOGIES LTD / XYLO Daily stock chart

XYLO Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 24.98 216.73B
ISRG INTUITIVE SURGICAL INC 66.52 203.04B
BSX BOSTON SCIENTIFIC CORP 32.45 141.90B
SYK STRYKER CORP 27.44 138.20B
IDXX IDEXX LABORATORIES INC 57.48 57.87B
BDX BECTON DICKINSON AND CO 14.06 57.87B
EW EDWARDS LIFESCIENCES CORP 32.3 48.17B
GEHC GE HEALTHCARE TECHNOLOGY 18.93 39.58B
RMD RESMED INC 26.04 37.64B
DXCM DEXCOM INC 38.16 27.68B
PODD INSULET CORP 60.95 19.60B
ZBH ZIMMER BIOMET HOLDINGS INC 11.3 18.12B

About XYLO

Company Profile

XYLO logo image Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).

Company Info

XYLO TECHNOLOGIES LTD

7A Industrial Park,, P.O. Box 3030

OMER IL

Employees: 38

XYLO Company Website

XYLO Investor Relations

Phone: 97286466880

XYLO TECHNOLOGIES LTD / XYLO FAQ

What does XYLO do?

Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).


What is the stock price of XYLO TECHNOLOGIES LTD today?

The current stock price of XYLO is 5.07 USD.


What is the dividend status of XYLO TECHNOLOGIES LTD?

XYLO does not pay a dividend.


How is the ChartMill rating for XYLO TECHNOLOGIES LTD?

XYLO has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the sector and industry classification for XYLO TECHNOLOGIES LTD?

XYLO TECHNOLOGIES LTD (XYLO) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Can you provide the PE ratio for XYLO stock?

XYLO TECHNOLOGIES LTD (XYLO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.46).


What is XYLO TECHNOLOGIES LTD worth?

XYLO TECHNOLOGIES LTD (XYLO) has a market capitalization of 9.61M USD. This makes XYLO a Nano Cap stock.


XYLO Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to XYLO. When comparing the yearly performance of all stocks, XYLO is one of the better performing stocks in the market, outperforming 78.82% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

XYLO Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to XYLO. Both the profitability and financial health of XYLO have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

XYLO Financial Highlights

Over the last trailing twelve months XYLO reported a non-GAAP Earnings per Share(EPS) of -3.46. The EPS increased by 66.37% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -16.05%
ROE -33.51%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%123.26%
Sales Q2Q%-72.47%
EPS 1Y (TTM)66.37%
Revenue 1Y (TTM)-67.45%

XYLO Forecast & Estimates

For the next year, analysts expect an EPS growth of 1216.67% and a revenue growth 5.71% for XYLO


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y1216.67%
Revenue Next Year5.71%

XYLO Ownership

Ownership
Inst Owners5.07%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A